Acute	acute	O	O	O	O
myocarditis	myocarditis	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
acute	acute	O	O	O	O
myocarditis	myocarditis	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
commencement	commencement	O	O	O	O
of	of	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
described	described	O	O	O	O
,	,	O	O	O	O
highlighting	highlighting	O	O	O	O
the	the	O	O	O	O
onset	onset	O	O	O	O
,	,	O	O	O	O
course	course	O	O	O	O
and	and	O	O	O	O
possible	possible	O	O	O	O
contributing	contributing	O	O	O	O
factors	factors	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
is	is	O	O	O	O
an	an	O	O	O	O
urgent	urgent	O	O	O	O
need	need	O	O	O	O
to	to	O	O	O	O
raise	raise	O	O	O	O
awareness	awareness	O	O	O	O
about	about	O	O	O	O
this	this	O	O	O	O
potentially	potentially	O	O	O	O
fatal	fatal	O	O	O	O
complication	complication	O	O	O	O
of	of	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
use	use	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
20-year-old	20-year-old	O	O	O	O
male	male	O	O	O	O
with	with	O	O	O	O
schizophrenia	schizophrenia	O	DISEASE	OTHERS	I
developed	developed	O	O	O	O
a	a	O	O	O	O
sudden	sudden	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
myocarditis	myocarditis	O	DISEASE	OTHERS	I
after	after	O	O	O	O
commencement	commencement	O	O	O	O
of	of	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
recovered	recovered	O	O	O	O
with	with	O	O	O	O
intensive	intensive	O	O	O	O
medical	medical	O	O	O	O
support	support	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
symptoms	symptoms	O	O	O	O
occurred	occurred	O	O	O	O
around	around	O	O	O	O
2	2	O	O	O	O
weeks	weeks	O	O	O	O
after	after	O	O	O	O
starting	starting	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
an	an	O	O	O	O
inpatient	inpatient	O	O	O	O
setting	setting	O	O	O	O
.	.	O	O	O	O

Possible	possible	O	O	O	O
contributing	contributing	O	O	O	O
factors	factors	O	O	O	O
may	may	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
concomitant	concomitant	O	O	O	O
antidepressant	antidepressant	CHEMICALS	O	OTHERS	I
use	use	O	O	O	O
and	and	O	O	O	O
unaccustomed	unaccustomed	O	O	O	O
physical	physical	O	O	O	O
activity	activity	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Myocarditis	myocarditis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
an	an	O	O	O	O
increasingly	increasingly	O	O	O	O
recognized	recognized	O	O	O	O
complication	complication	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
can	can	O	O	O	O
be	be	O	O	O	O
fatal	fatal	O	O	O	O
if	if	O	O	O	O
not	not	O	O	O	O
recognized	recognized	O	O	O	O
and	and	O	O	O	O
treated	treated	O	O	O	O
early	early	O	O	O	O
.	.	O	O	O	O

Considering	considering	O	O	O	O
that	that	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
remains	remains	O	O	O	O
the	the	O	O	O	O
gold	gold	O	O	OTHERS	I
standard	standard	O	O	O	O
in	in	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
resistant	resistant	O	O	O	O
psychosis	psychosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
there	there	O	O	O	O
is	is	O	O	O	O
an	an	O	O	O	O
urgent	urgent	O	O	O	O
need	need	O	O	O	O
to	to	O	O	O	O
raise	raise	O	O	O	O
awareness	awareness	O	O	O	O
among	among	O	O	O	O
medical	medical	O	O	O	O
and	and	O	O	O	O
paramedical	paramedical	O	O	O	O
staff	staff	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
care	care	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
are	are	O	O	O	O
also	also	O	O	O	O
implications	implications	O	O	O	O
for	for	O	O	O	O
recommendations	recommendations	O	O	O	O
and	and	O	O	O	O
regulations	regulations	O	O	O	O
regarding	regarding	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

